GOP, Dems Unite Behind Drug Bill 09/18 06:22
WASHINGTON (AP) -- Republicans and Democrats joined forces to speed
legislation combating the misuse of opioids and other addictive drugs through
Senate passage Monday, a rare campaign-season show of unity against a growing
and deadly health care crisis.
The measure passed by a 99-1 vote Monday evening. Sen. Mike Lee, R-Utah,
voted against it.
It takes wide aim at the problem, including increasing scrutiny of arriving
international mail that may include illegal drugs. It makes it easier for the
National Institutes of Health to approve research on non-addictive painkillers
and for pharmaceutical companies to conduct that research. The Food and Drug
Administration would be allowed to require drug makers to package smaller
quantities of drugs like opioids. And there would be new federal grants for
treatment centers, training emergency workers and research on prevention
Lawmakers' focus on combating opioids comes amid alarming increases in drug
overdose deaths, with the government estimating more than 72,000 of them last
year. That figure has grown annually and is double the 36,000 who died in 2008.
Besides the sheer numbers, Congress has been drawn to the problem because of
its broad impact on Republican, Democratic and swing states alike.
California, Florida, Ohio and Pennsylvania each had more than 4,000 people
die from drug overdoses in 2016, while seven other states each lost more than
2,000 people to drugs, according to the most recent figures available. The
states with the highest death rates per resident include West Virginia,
Pennsylvania, Ohio and New Hampshire, along with the District of Columbia.
West Virginia Sen. Joe Manchin and Florida Sen. Bill Nelson, both Democrats,
are among those facing competitive re-election races in November's midterm
elections. Republicans are trying to deflect a Democratic effort to capture
Money for much of the federal spending the legislation envisions would have
to be provided in separate spending bills.
The House approved its own drug legislation this summer. Congressional
leaders hope the two chambers will produce compromise legislation and send it
to President Donald Trump for his signature by year's end.